TUL was established in Hong Kong in 1990, which is a leading integrated pharmaceutical group company in China that researches, develops, manufactures, markets bulk medicines and intermediate products as well as finished products. Through more than 3 decades of development in China, TUL has grown into one of the largest antibiotics manufacturers in the world. TUL has 6 subsidiary plants nationwide across China altogether with employees totaling more than 10,000, whose products have been sold in 5 continents up to 60 countries. June 15,2007 saw TUL successfully listed in Hong Kong exchange(03933.HK. So far, Dozens of products by TUL have passed certification of EU-GMP, FDA, China GMP. Looking ahead, TUL stays committed to be in a pursuit of an objective of provision of superior quality medicines and products, aspiring with a dedication to promotion of the well-being of millions of people within China and around the world. We are energized by our pursuit, because we know significance of the mission we pursue: “ to make life more valuable”.
Year Established: 1990
Total Assets(USD): More than 99,999,999
Total Number of Staff: more than 1000
Main Competitive Advantages: Brand Name,International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production Capacity,Large Product Line,Buyers' Specifications Accepted,Small Orders Accepted,Reputation,Quality Service
Business Type: Trading Company,Manufacturer
R&D Capacity: Own Brand
Annual Turnover(USD) : More than 99,999,999
Main Sales Markets : Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Subscribe to the latest newsletter of Virtual Expo Connect